Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Mesothelioma Of The Pleura: A Study Of 52 Treated And 64 Untreated Patients.

M. Law, A. Gregor, M. Hodson, H. Bloom, M. Turner-Warwick
Published 1984 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We have carried out sequential prospective studies of treatment with surgery alone, chemotherapy, and radiotherapy in malignant mesothelioma of the pleura. The survival of treated patients was contrasted with that of 64 contemporary untreated patients whose clinical condition at presentation was comparable with that of the treated patients. Non-radical surgery alone (28 patients) was of palliative benefit, particularly for the control of recurrent pleural effusions, and may have prolonged survival in one patient with localised malignant mesothelioma. Chemotherapy with doxorubicin, vincristine, and cyclophosphamide (12 patients, with preceding surgery in eight) was without objective benefit. Megavoltage radiotherapy by an off axis beam rotational technique (12 patients, with preceding surgery in eight) abolished pain and dyspnoea and may have prolonged survival in one patient and terminated recurrent pleural effusions in three, but it was of no value in the other patients. There was no significant difference in survival between treatment groups or between treated and untreated patients, and no difference when mesotheliomas of epithelial, sarcomatous, and mixed cell types were examined separately. Treatment of this disease appeared to fail because of the unresponsiveness of the tumour to existing forms of treatment and the advanced stage of the disease at clinical presentation.
This paper references
10.1016/S0012-3692(15)37393-1
Malignant mesothelioma. Current status and future prospects.
J. Aisner (1978)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
Pleural mesothelioma -an analysis of 18 cases and review of the literature
D A Taryle (1976)
10.1016/S0022-5223(19)40189-X
Malignant pleural mesothelioma. Report of 19 cases.
J. Shearin (1976)
10.1016/0007-0971(81)90027-9
Diffuse malignant pleural mesothelioma in Glasgow.
A. J. Dorward (1981)
10.1378/CHEST.64.5.641
Mesothelioma following exposure to asbestos: a review of 72 cases.
M. Borow (1973)
10.2214/AJR.99.4.863
Pleural mesotheliomas. Clinical experiences with thirty-seven patients.
E. R. Ratzer (1967)
10.1016/0002-9343(80)90103-5
Multimodality therapy for malignant mesothelioma based on a study of natural history.
K. H. Antman (1980)
10.1097/00000421-198208000-00014
Chemotherapy for malignant mesothelioma: CAMEO
J. Jett (1982)
Transplantation of human malignant mesothelioma into nude mice.
A. Chahinian (1980)
10.1159/000224951
Chemotherapy of malignant mesothelioma.
R. Gerner (1974)
10.1002/1097-0142(19821001)50:7<1245::AID-CNCR2820500704>3.0.CO;2-H
High‐dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma
N. Dimitrov (1982)
Treatment of diffuse malignant mesothelioma: a review.
A. Chahinian (1978)
Malignant mesothelioma of the pleura.
K. Sirola (1959)
Pleural mesotheliomas -clinical experience with 37 patients
J Aisner (1967)
10.1148/92.1.130
Shaping the dose distribution through a tumor model.
B. S. Proimos (1969)
10.1136/thx.37.11.810
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour.
M. Law (1982)
10.1016/S0022-5223(19)41262-2
Localized mesothelioma of the pleura: benign and malignant variants.
N. Okike (1978)
10.1378/CHEST.60.6.564
Diffuse malignant mesothelioma of the pleura: a review of 37 cases.
H. Oels (1971)
10.1016/S0305-7372(77)80016-9
Therapeutic approaches in malignant mesothelioma.
S. Legha (1977)
10.1016/S0003-4975(10)61316-1
Diffuse, mixed malignant pleural mesothelioma.
R. Lewis (1981)
The role of surgery in diffuse malignant mesothelioma of the pleura.
E. Butchart (1981)
10.1093/OXFORDJOURNALS.QJMED.A067473
The clinical aspects of mesothelioma.
P. Elmes (1976)
Pleural mesothelioma. Cancer 1976;38:2481-8
B Hilaris (1976)
La radiotherapie des mesotheliomes pleuraux malins
F Eschwege (1973)
Pleural mesotheliomas -clinical experience with 37 patients
E R Ratzer (1967)
10.6004/JNCCN.2012.0006
[Malignant pleural mesothelioma].
Q. Kong (1983)
10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W
Malignant mesothelioma of the pleura: Review of 123 patients
J. Brenner (1982)
10.1002/1097-0142(197810)42:4<1692::AID-CNCR2820420406>3.0.CO;2-Y
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma
B. S. Yap (1978)
10.1007/978-0-387-88441-7_26
[Pleural mesothelioma].
A. DE GASPERIS (1950)
10.1136/thx.26.1.6
Diffuse malignant pleural mesothelioma and asbestos exposure
F. Whitwell (1971)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
10.1097/00005792-197603000-00004
PLEURAL MESOTHELIOMAS—AN ANALYSIS OF 18 CASES AND REVIEW OF THE LITERATURE
D. A. Taryle (1976)
10.1016/0360-3016(82)90379-0
Radiation therapy in the management of patients with mesothelioma.
W. Gordon (1982)



This paper is referenced by
10.1177/014107688908200302
Malignant Mesothelioma
R. Rudd (1989)
10.1093/OXFORDJOURNALS.ANNONC.A059253
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma.
A. Planting (1995)
10.1097/JTO.0b013e3181834f66
Recent Advances in the Treatment of Malignant Pleural Mesothelioma
S. Ramalingam (2008)
10.7861/CLINMEDICINE.3-4-314
Recent advances in mesothelioma.
G. Dark (2003)
10.1007/BF01606452
Diffuse malignant mesothelioma of the pleura: A clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival
E. Mark (2005)
10.1007/978-1-4419-7098-5_6
Malignant Pleural Mesothelioma
T. Peikert (1995)
10.1016/0022-4804(92)90141-L
Adriamycin enhanced in vitro and in vivo photodynamic therapy of mesothelioma.
P. Brophy (1992)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
10.1016/S1547-4127(04)00108-2
External beam radiation therapy for the treatment of pleural mesothelioma.
E. Baldini (2004)
10.1093/ANNONC/MDF664
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
G. Jerusalem (2002)
Surgical treatment of malignant pleural mesothelioma: a review
S. V. Ruth (2009)
10.1200/JCO.1993.11.6.1172
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.
D. Sugarbaker (1993)
10.1016/0022-4804(90)90070-I
In vitro killing of human malignant mesothelioma by photodynamic therapy.
S. Keller (1990)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
10.1378/CHEST.109.1.109
Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.
L. Johansson (1996)
10.1016/j.cllc.2019.08.008
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
D. Franceschini (2019)
10.1016/S1547-4127(04)00110-0
Pleurectomy and decortication for malignant mesothelioma.
S. Cowan (2004)
10.5798/DICLEMEDJ.0921.2012.04.0191
Malign plevral mezotelyoma hastalarında destek tedavisi ve plöredezin karşılaştırılması
Abdullah Cetin Tanrıkulu (2012)
10.1016/J.CLON.2006.12.006
The role of radiotherapy in the treatment of malignant pleural mesothelioma.
K. Waite (2007)
Radiotherapy for malignant pleural mesothelioma (Review)
E. Chapman (2010)
10.17925/OHR.2008.04.1.60
Malignant Pleural Mesothelioma—A Current Review
Marc S. Ballas (2008)
10.1002/14651858.CD003880.PUB4
Radiotherapy for malignant pleural mesothelioma.
E. Chapman (2006)
10.1007/0-387-31056-8_38
Therapy for malignant pleural mesothelioma
H. Pass (2006)
10.1016/J.PNEUMO.2010.07.013
Traitement de seconde ligne dans le mésothéliome pleural malin. Étude rétrospective française (2005–2006)
J. Margery (2010)
10.1159/000061159
Resection and IORT followed by three-dimensional conformal radiotherapy with or without adjuvant chemotherapy for malignant mesothelioma.
D. Jablons (1997)
10.1016/S0003-4975(10)61179-4
Thoracic surgical problems in asbestos-related disorders.
E. Gaensler (1985)
10.1586/14737140.8.2.293
Current concepts in malignant pleural mesothelioma
A. Kaufman (2008)
10.1200/JCO.1996.14.3.878
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.
P. Soulié (1996)
10.1016/S0025-6196(12)65411-1
Malignant mesothelioma of the pleura.
R. J. Pisani (1988)
10.1038/bjc.1994.86
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice.
S. L. Gibson (1994)
10.1002/JSO.1143
Survival after conservative (palliative) management of pleural malignant mesothelioma
N. Merritt (2001)
10.3109/07357909609018904
Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers.
B. Mossman (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar